Rasbridge S A, Millis R R
ICRF Clinical Oncology Unit, Guy's Hospital, London, UK.
Histopathology. 1995 Sep;27(3):269-73. doi: 10.1111/j.1365-2559.1995.tb00220.x.
The distinction between invasive and in situ carcinoma of the breast is important with regard to the treatment and prognosis of the patient. When carcinoma in situ involves breast tissue in which the normal architecture is altered by pre-existing sclerosing adenosis, the resulting histological picture may closely mimic an invasive carcinoma. We record the histopathological features in 13 cases where there was difficulty in identifying the presence or extent of invasive carcinoma. The most useful clue was attention to the low power appearances of distorted lobular units in the areas of malignancy and comparison with surrounding breast tissue which usually showed recognizable sclerosing adenosis. The use of immunohistochemical stains for myoepithelium (alpha-actin and S-100 protein) and for basement membrane (collagen type IV and laminin) proved to be of considerable value in identifying the preservation of these features around glandular structures in areas of sclerosing adenosis containing in situ carcinoma.
乳腺浸润性癌与原位癌的区分对于患者的治疗和预后至关重要。当原位癌累及乳腺组织,而该组织的正常结构因先前存在的硬化性腺病而改变时,所产生的组织学图像可能与浸润性癌极为相似。我们记录了13例难以确定浸润性癌的存在或范围的组织病理学特征。最有用的线索是关注恶性区域中扭曲小叶单位的低倍镜表现,并与通常显示可识别的硬化性腺病的周围乳腺组织进行比较。事实证明,使用免疫组织化学染色检测肌上皮(α-肌动蛋白和S-100蛋白)和基底膜(IV型胶原和层粘连蛋白)对于确定原位癌所在的硬化性腺病区域中腺管结构周围这些特征的保留情况具有重要价值。